Alantra advises The Riverside Company on the acquisition financing for Dastex Reinraumzubehör GmbH
SECTORHealthcare
ServiceAcquisition Financing
Germany – Alantra has advised The Riverside Company, a global private investor focused on the middle market, on the acquisition financing for Dastex Reinraumzubehör GmbH, a European leader in textile cleanroom garments and cleanroom consumables.
Founded over 30 years ago, Riverside is a global private investor focused on the smaller end of the middle market fostering long-term growth through fundamental operating improvements and add-on acquisitions.
Established in 1979 in Germany, Dastex has grown to become a market leading provider of both third-party brand and proprietary garments and consumables for cleanrooms in Germany, Austria, and Switzerland with a strong footprint in Benelux and a growing pan-European presence. The company has grown rapidly in recent years, driven by its unique technical know-how and R&D capabilities, comprehensive product assortment and excellent customer service, meeting strong demand from the pharmaceutical and semiconductor industries.
Damien Gaudin, Partner at The Riverside Company, commented on the transaction: “The attractive financing package structured by Alantra provides us with the flexibility to follow our pan-European buy-and-build strategy. We would like to thank the Alantra team for their excellent debt advisory services.”
Maximilian Rohardt, Partner for Debt Advisory in Alantra’s Frankurt office, added: “We would like to congratulate the Riverside team on an outstanding deal and thank them for their trust. The fast-paced and highly competitive financing process resulted in a well-suited financing offer to win the transaction as well as the flexibility for the envisaged growth strategy.”
The transaction was managed by Alantra’s Frankfurt Office: Maximilian Rohardt and Philipp Holst.
The parties agreed to keep the information of the transaction confidential.
Related Transactions
-
Dec 2024Corporate BrokerDec 2024SECTOR HealthcareService Corporate Broker; Equity Capital Markets
-
Oct 2024Sell-side advisoryOct 2024SECTOR HealthcareService M&A
-
Oct 2024Sell-side advisoryOct 2024SECTOR Consumer Goods & Retail; HealthcareService M&A
-
Oct 2024Sell-side advisoryOct 2024SECTOR Consumer Goods & Retail; HealthcareService M&A